Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106518663B reveals metal-free synthesis for alpha-acyloxy ketones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111777536A reveals a metal-free route to N-phenyl-3-(phenyldisulfanyl)propionamide using NFSI, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN101935309A reveals a novel Ezetimibe synthesis using indeno-oxazole auxiliaries, offering 99.97% ee and scalable manufacturing for reliable API intermediate supply chains.
Novel visible light method reduces metal waste. Enhances supply chain stability for high-purity pharmaceutical intermediates. Cost-effective scalable production.
Novel palladium-catalyzed water-based method for asymmetric biphenyl. Reduces cost and environmental impact for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed synthesis reduces costs and simplifies supply chains for high-purity pharmaceutical intermediates using mild conditions and efficient processes.
Patent CN115141184A reveals acid-catalyzed route boosting yield to 70%, offering cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN103524575A details a green synthesis route for beta-arbutin, offering significant cost reduction in skin whitening agent manufacturing through solvent recycling.
Patent CN107188792A reveals a novel [4+2] cyclization for 2,4'-dihydroxybenzophenone. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Discover a novel, metal-free synthesis method for oseltamivir phosphate. Eliminate sodium azide risks and palladium costs with our high-yield industrial process.
Novel rare earth catalyzed synthesis offers high yield and mild conditions for aminoisoindole derivatives, ensuring cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel zirconium catalyst method for chiral alpha-hydroxy-beta-keto esters. High yield, excellent ee, cost-effective industrial scale-up for pharmaceutical intermediates.
Patent CN102558083B reveals solvent-free isoxazole synthesis enabling cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN116199597B reveals a novel diazonium salt catalyst enabling mild synthesis of indole derivatives with substantial cost and supply chain advantages for global buyers.
Patent CN102603566B details a room-temperature asymmetric synthesis of chiral amino nitriles using copper catalysis, offering mild conditions for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed method for sulfonylureas eliminates phosgene risks. Cost-effective scalable manufacturing for pharmaceutical intermediates ensuring supply chain reliability and high purity.
Patent CN101857566B reveals a novel one-pot method for 2-hydroxypyridines, offering cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN108822072B details a high-yield diastereoselective Aldol route for Eliglustat intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Advanced synthesis of soluble polymer-supported chiral auxiliaries from L-tyrosine. Enhances asymmetric induction efficiency and simplifies purification for pharmaceutical manufacturing.
Patent CN110776510A reveals a novel iodine-catalyzed one-pot synthesis for 1-(2-quinolinyl)-β-carboline natural products, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.